跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PIM-1 inhibitors (cancer)
首页
药物
PIM-1 inhibitors (cancer)
PIM-1 inhibitors (cancer)
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Chemical compounds 251
US 8901307 B2
申请人: DAKIN LESLIE
优先权: 2008
CN
US
4 件公开
Bicyclic compounds as Pim inhibitors
EP 2796456 A1
申请人: AMGEN INC
优先权: 2010
EP
US
3 件公开
Azole compounds as PIM inhibitors
US 9321756 B2
申请人: WANG HUI-LING
优先权: 2012
US
2 件公开
Bicyclic pyridazine compounds as Pim inhibitors
US 9187486 B2
申请人: D AMICO DERIN C
优先权: 2012
US
2 件公开
IMIDAZO[1,2-beta]PYRIDAZINE AND PYRAZOLO[1,5-alpha]PYRIMIDINE DERIVATIVES AND THEIR USE AS PROTEIN KINASE INHIBITORS
US 2008261988 A1
申请人: SUPERGEN INC
优先权: 2007
US
Inhibitors of PIM-1 Protein Kinases, Compositions and Methods for Treating Prostate Cancer
US 2011263664 A1
申请人: MUSC FOUND FOR RES DEV
优先权: 2007
US
Amides as pim inhibitors
US 9394297 B2
申请人: AMGEN INC
优先权: 2013
US
Compounds
CN 118401527 A
申请人: FUNDACIO CENTRO NAC DE INVESTIGACIONES ONCOLOGICAS CARLOS III F S P CNIO
优先权: 2021
CN
药物
反馈